These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 2221865)

  • 21. Cefetamet pivoxil: a review of its microbiology, toxicology, pharmacokinetics and clinical efficacy.
    Cullmann W; Edwards DJ; Kissling M; Kneer J; Stoeckel K; Urwyler H
    Int J Antimicrob Agents; 1992; 1(4):175-91. PubMed ID: 18611503
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cefetamet pivoxil a new oral cephalosporin: clinical evaluation.
    Kissling M; Germano G; Fernex M
    Chemotherapy; 1988; 34(6):519-29. PubMed ID: 3243094
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Clinical experience with 1000 patients treated with cefetamet pivoxil.
    Bernstein-Hahn L; Valdés E; Gehanno P; Giamarellou H; Lassus A; Ulmer WT; Vetter N; Walhor F; Wettengel R; Fernex M
    Curr Med Res Opin; 1989; 11(7):442-52. PubMed ID: 2673664
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cefetamet pivoxil in acute pyelonephritis: an open study.
    Stathakis C; Roulleau N; Libert M; Germano G; Kissling M
    Curr Med Res Opin; 1990; 12(1):43-50. PubMed ID: 2188796
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cefetamet pivoxil in community-acquired pneumonia: an overview.
    Kissling M
    Curr Med Res Opin; 1992; 12(10):631-9. PubMed ID: 1633721
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Antimicrobial prophylaxis in pregnancy: a randomized, placebo-controlled trial with cefetamet-pivoxil in pregnant women with a poor obstetric history.
    Gichangi PB; Ndinya-Achola JO; Ombete J; Nagelkerke NJ; Temmerman M
    Am J Obstet Gynecol; 1997 Sep; 177(3):680-4. PubMed ID: 9322642
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Comparative clinical efficacy of cefetamet pivoxil in lower respiratory tract infection.
    Grassi GG
    Drugs; 1994; 47 Suppl 3():35-42. PubMed ID: 7518765
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Different doses of cefetamet pivoxil (Ro 15-8075) in the treatment of acute uncomplicated gonococcal urethritis in men.
    Tio TT; Sindhunata IR; Wagenvoort JH; Michel MF; Stolz E
    Antimicrob Agents Chemother; 1990 Apr; 34(4):674-5. PubMed ID: 2111660
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cefetamet pivoxil in otitis media.
    Quevedo A; Sossouhounto R; Kissling M
    ORL J Otorhinolaryngol Relat Spec; 1993; 55(2):93-6. PubMed ID: 8446394
    [TBL] [Abstract][Full Text] [Related]  

  • 30. In vitro antibacterial properties of cefetamet and in vivo activity of its orally absorbable ester derivative, cefetamet pivoxil.
    Angehrn P; Hohl P; Then RL
    Eur J Clin Microbiol Infect Dis; 1989 Jun; 8(6):536-43. PubMed ID: 2504597
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Impact of cefetamet-pivoxil on intestinal microflora: in vivo study.
    Gismondo MR; Drago L; Lombardi A; Fassina C
    J Chemother; 1994 Aug; 6(4):246-50. PubMed ID: 7830102
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Using Monte Carlo simulation to determine optimal dosing regimen for cefetamet sodium for injection.
    Li C; Sun J; Miao J; Qin Y; Wang Y; Yu R; Xiao Y
    J Chemother; 2016 Jun; 28(3):172-9. PubMed ID: 25252727
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cefetamet pivoxil: comparable evaluation with other orally available antibiotics against selected species of respiratory pathogens.
    Speciale A; Caccamo F; Blandino G; Giacchi GT; Aleo G; Nicoletti G
    Chemotherapy; 1996; 42(1):1-10. PubMed ID: 8751262
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cefetamet pivoxil in the treatment of pharyngotonsillitis due to group A beta-hemolytic streptococci: preliminary report.
    Gervaix A; Brighi L; Halpérin DS; Suter S
    J Chemother; 1995 May; 7 Suppl 1():21-4. PubMed ID: 8618109
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effects of cefetamet (Ro 15-8074) on Treponema pallidum and experimental syphilis.
    Fitzgerald TJ
    Antimicrob Agents Chemother; 1992 Mar; 36(3):598-602. PubMed ID: 1622168
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A Randomized, Crossover Study on the Effect of Food on the Pharmacokinetic Characteristics of Morphine ARER (MorphaBond™ ER), an Abuse-Deterrent Formulation of Extended-Release Morphine.
    Kinzler ER; Pantaleon C; Iverson M; Aigner S
    Adv Ther; 2019 Sep; 36(9):2394-2401. PubMed ID: 31278694
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effect of timing of food on absorption of cefpodoxime proxetil.
    Borin MT; Driver MR; Forbes KK
    J Clin Pharmacol; 1995 May; 35(5):505-9. PubMed ID: 7657851
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cefetamet pivoxil in pediatric otitis media.
    Pukander JS; Paloheimo SH; Sipilä MM
    Chemotherapy; 1992; 38 Suppl 2():25-8. PubMed ID: 1516461
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Quantitative determination of cefetamet in human plasma by liquid chromatography-mass spectrometry.
    Noh K; Kim E; Kang W
    Biomed Chromatogr; 2011 Jul; 25(7):779-82. PubMed ID: 20845371
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Food increases the bioavailability of mefloquine.
    Crevoisier C; Handschin J; Barré J; Roumenov D; Kleinbloesem C
    Eur J Clin Pharmacol; 1997; 53(2):135-9. PubMed ID: 9403285
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.